
Immunotherapy for Cancer - NCI
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Learn about the types of immunotherapy and what you can expect during treatment.
Side Effects of Immunotherapy - NCI - National Cancer Institute
Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the types of side effects …
Immune Checkpoint Inhibitors - NCI - National Cancer Institute
Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins. Learn about the cancers treated with checkpoint inhibitors and the side …
Immunotherapy Combo Approved for dMMR Colorectal Cancer
May 2, 2025 · The Food and Drug Administration (FDA) has approved the combination of two immunotherapy drugs for the initial treatment of some people with advanced colorectal cancer.
Definition of immunotherapy - NCI Dictionary of Cancer Terms
Immunotherapy uses the body’s immune system to fight cancer. This animation explains three types of immunotherapy used to treat cancer: nonspecific immune stimulation, T-cell transfer therapy, and …
T-cell Transfer Therapy - Immunotherapy - NCI
How does T-cell transfer therapy work against cancer? T-cell transfer therapy is a type of immunotherapy that makes your own immune cells better able to attack cancer. There are two main …
AI Tool May Help Guide Use of Cancer Immunotherapy - NCI
Feb 26, 2025 · A class of immunotherapy drugs called immune checkpoint inhibitors have proven transformative for people with some types of cancer. In a small number of patients with advanced …
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Feb 26, 2025 · Just a decade or so ago, immunotherapy was considered an exciting new way to treat some people with very advanced forms of a few types of cancer. Today, it’s a cornerstone of cancer …
Imfinzi, Keytruda Approved for Some Endometrial Cancers
Aug 6, 2024 · FDA has approved three new immunotherapy options, including pembrolizumab (Keytruda) and durvalumab (Imfinzi), with chemo for advanced endometrial cancer.
TIL therapy for metastatic gastrointestinal cancers - NCI
Apr 1, 2025 · “We see a little crack in the solid wall of cancer by using cell-based immunotherapy for the common solid cancers, and we think we have ways to open that crack even further.”